Yi Cai

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Radical Prostatectomy

Long Noncoding Rna

Top Venues

Annals of medicine

Clinical and translational medicine

The Journal of urology

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Cai, Minfeng Chen, Yuchen Gong, Guyu Tang, Zhiwei Shu, Jiaxian Chen, Hengfeng Zhou, Yao He, Zhi Long, Yu Gan
Androgen-repressed lncRNA LINC01126 drives castration-resistant prostate cancer by regulating the switch between O-GlcNAcylation and phosphorylation of androgen receptor. Clinical and translational medicine 14 (1) (2024)
Honghu Zhang, Lin Qi, Yi Cai, Xiaomei Gao
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer. Annals of medicine 56 (1) (2024)
Honghu Zhang, Lin Qi, Yi Cai, Xiaomei Gao
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer. Annals of medicine 56 (1) (2024)
Yi Cai, Minfeng Chen, Yuchen Gong, Guyu Tang, Zhiwei Shu, Jiaxian Chen, Hengfeng Zhou, Yao He, Zhi Long, Yu Gan
Androgen-repressed lncRNA LINC01126 drives castration-resistant prostate cancer by regulating the switch between O-GlcNAcylation and phosphorylation of androgen receptor. Clinical and translational medicine 14 (1) (2024)
Honghu Zhang, Lin Qi, Yi Cai, Xiaomei Gao
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer. Annals of medicine 56 (1) (2024)
Honghu Zhang, Lin Qi, Yi Cai, Xiaomei Gao
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer. Annals of medicine 56 (1) (2024)
Yi Cai, Minfeng Chen, Yuchen Gong, Guyu Tang, Zhiwei Shu, Jiaxian Chen, Hengfeng Zhou, Yao He, Zhi Long, Yu Gan
Androgen-repressed lncRNA LINC01126 drives castration-resistant prostate cancer by regulating the switch between O-GlcNAcylation and phosphorylation of androgen receptor. Clinical and translational medicine 14 (1) (2024)
Honghu Zhang, Lin Qi, Yi Cai, Xiaomei Gao
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer. Annals of medicine 56 (1) (2024)
Xingming Wang, Li Zhou, Lin Qi, Ye Zhang, Hongling Yin, Yu Gan, Xiaomei Gao, Yi Cai
High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate. Prostate cancer and prostatic diseases (2023)
Xiaomei Gao, Yongxiang Tang, Minfeng Chen, Jian Li, Hongling Yin, Yu Gan, Xiongbin Zu, Yi Cai, Shuo Hu
A prospective comparative study of [ 68 Ga]Ga-RM26 and [ 68 Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer. European journal of nuclear medicine and molecular imaging (2023)
Wei Tang, Yongxiang Tang, Lin Qi, Ye Zhang, Guyu Tang, Xiaomei Gao, Shuo Hu, Yi Cai
Reply By Authors. The Journal of urology (2023)
Wei Tang, Yongxiang Tang, Lin Qi, Ye Zhang, Guyu Tang, Xiaomei Gao, Shuo Hu, Yi Cai
BPH-related False Positive of PSMA-PET in the Diagnosis of Prostate Cancer: the Achilles' Heel of Biopsy-free Radical Prostatectomy? The Journal of urology (2023)
Cong Luo, Wen-Rui Ye, Wei Shi, Ping Yin, Chen Chen, Yun-Bo He, Min-Feng Chen, Xiong-Bin Zu, Yi Cai
Perfect match: mTOR inhibitors and tuberous sclerosis complex. Orphanet journal of rare diseases 17 (1) (2022)
Cong Luo, Ye Zhang, Yu-Shi Zhang, Ming-Xin Zhang, Jun Ning, Min-Feng Chen, Yuan Li, Lin Qi, Xiong-Bing Zu, Yang-Le Li, Yi Cai
Renal phenotypes correlate with genotypes in unrelated individuals with tuberous sclerosis complex in China. Orphanet journal of rare diseases 17 (1) (2022)
Yinzhao Wang, Yongxiang Tang, Xiaomei Gao, Yu Gan, Shuo Hu, Min-Feng Chen, Yi Cai
Optimization of prostate cancer patient lymph node staging via the integration of neutrophil-lymphocyte ratios, platelet-lymphocyte ratios, and 68 Ga-PSMA-PET-derived SUVmax values. The Prostate 82 (15) (2022)
Cong Luo, Zhi Liu, Yu Gan, Xiaomei Gao, Xiongbing Zu, Ye Zhang, Wenrui Ye, Yi Cai
SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer. Journal of translational medicine 20 (1) (2022)
Dong-Xu Qiu, Jian Li, Jin-Wei Zhang, Min-Feng Chen, Xiao-Mei Gao, Yong-Xiang Tang, Ye Zhang, Xiao-Ping Yi, Hong-Ling Yin, Yu Gan, Gui-Lin Wang, Xiong-Bing Zu, Shuo Hu, Yi Cai
Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study. European journal of nuclear medicine and molecular imaging (2021)